PHARMACEUTICAL RESEARCH - AN OVERVIEW

Antibody avidity fulfills multiple myeloma In the continuing try to find impressive treatments to overcome refractory and relapsed most cancers, new preclinical perform in various myeloma exhibits that expanding binding avidity by targeting two antigens in one T cell-participating trispecific antibody boosts anti-tumor exercise and reduces the prob